To demonstrate this hypothesis, we compared the development of insulin resistance, DM, and the progression of diabetic nephropathy between diabetic and non-diabetic transgenic (TG) mice overexpressing human TGFβ1 in the kidneys and wild-type (WT) mice. The gene discussed is TGFB1; the disease is diabetic kidney disease.